Kenya - English - Pharmacy and Poisons Board

astrazeneca parklands alderley park macclesfield cheshire - saxagliptin and metformin hydrochloride - film-coated tablet - each tablet contains 5 mg saxagliptin and 1000 mg… - combinations of oral blood glucose lowering drugs

Kenya - English - Pharmacy and Poisons Board

astrazeneca parklands alderley park macclesfield cheshire - saxagliptin and metformin hydrochloride - film-coated tablet - each tablet contains 5 mg saxagliptin and 1000 mg… - combinations of oral blood glucose lowering drugs

Kenya - English - Pharmacy and Poisons Board

astrazeneca parklands alderley park macclesfield cheshire - saxagliptin - film-coated tablet - each tablet contains 2.5 mg saxagliptin - blood glucose lowering drugs excluding insulins:

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

de pharmaceuticals - metformin hydrochloride - tablet - 850mg

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

astrazeneca camcar, s.a. - saxagliptina - saxagliptina....5.0 mg / metformina clorhidrato....1000.0 mg

Australia - English - Department of Health (Therapeutic Goods Administration)

bristol-myers squibb australia pty ltd - saxagliptin -

United States - English - NLM (National Library of Medicine)

astrazeneca pharmaceuticals lp - dapagliflozin (unii: 1ull0qj8uc) (dapagliflozin - unii:1ull0qj8uc), saxagliptin hydrochloride (unii: z8j84yix6l) (saxagliptin anhydrous - unii:8i7io46ivq) - dapagliflozin 10 mg - qtern is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. limitations of use qtern is not recommended for use to improve glycemic control in patients with type 1 diabetes mellitus [see warnings and precautions (5.1) ] . qtern is contraindicated in patients with: risk summary based on animal data showing adverse renal effects from dapagliflozin, qtern is not recommended during the second and third trimesters of pregnancy. the limited available data with qtern or its components (dapagliflozin and saxagliptin) in pregnant women are not sufficient to determine a drug-associated risk for major birth defects or miscarriage. there are risks to the mother and fetus associated with poorly controlled diabetes in pregnancy (see clinical considerations) . in animal studies, adverse renal pelvic and tubular dilatations, that were not fully reversible, were observed in rats when dapagliflozin (a component of qtern) was administered during a period of renal

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

astrazeneca ab, sweden - metformin hydrochloride,saxagliptin - extended-release tablet - 500,5 mg,

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

astrazeneca ab, sweden - metformin hydrochloride,saxagliptin - extended-release tablet - 1000,5 mg,

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

astrazeneca ab, sweden - metformin hydrochloride,saxagliptin - extended-release tablet - 1000,2.5 mg,